Role of Selective Coronary Arteriography in Patients with Cardiac Myxoma

Cheng, Tsung O.

doi:10.1159/000047328

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Echocardiography, computed tomography, and magnetic resonance imaging are the usual diagnostic tools for cardiac myxoma [5][6][7]. Coronary angiography (CAG) is also indicated for patients with myxoma before surgical excision to confirm or exclude the presence of coexisting coronary artery disease (CAD) [8][9][10]. Consequently, angiographically detectable neovascularity (ADN) is increasingly being reported, and some reports have suggested that ADN might cause a "coronary steal phenomenon," which might be responsible for the pathogenesis of ischemic symptoms in patients with myxoma [11,12].…”

Section: Introductionmentioning

confidence: 99%

Clinical Significance of Angiographically Detectable Neovascularity in Patients with Cardiac Myxoma

Zhou

2021

CVIA

View full text Add to dashboard Cite

Background: Myxomas are the most common primary cardiac tumors. Angiographically detectable neovascularity (ADN) of myxoma is increasingly being reported as a result of the use of coronary angiography (CAG) to detect coronary artery disease. However, the clinical significance of these findings is not fully understood.Methods: We enrolled 59 patients with cardiac myxoma who also underwent CAG between January 2013 and October 2018. Patients were followed up for a mean of 28.9 months (range 1–69 months). The clinical features, echocardiography measurements, pathological examination findings, CAG results, and outcomes during follow-up were compared between patients with ADN and patients without ADN.Results: ADN was found in 25 patients (42.4%). The arteries feeding the ADN included the right coronary artery(n = 15), the left circumflex coronary artery (n = 7), and both arteries (n = 3). The patients with ADN had a higherproportion of eosinophils (3.2% vs. 2.2%, P = 0.03) and higher low-density lipoprotein cholesterol level (2.7 mmol/L vs.2.2 mmol/L, P = 0.02). Myxoma pedicles were more likely to be located in the interatrial septum in patients with ADN(96% vs. 73.5%, P = 0.02). No significant correlation was observed between the groups in clinical manifestations, atrialarrhythmia, myxoma size, cardiac chamber size, left ventricular ejection fraction, and the prevalence of complicationwith coronary artery disease [16% in the ADN group (n = 4) vs. 20.6% in the non-ADN group (n = 7), P = 0.66].However, patients with ADN tended to have a lower incidence of major adverse cardiac and cerebrovascular events onlong-term follow-up (0% vs. 14.7%, P = 0.07).Conclusion: CAG-detected ADN in patients with cardiac myxoma is associated with a borderline lower rate of major adverse cardiac and cerebrovascular events.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinical Significance of Angiographically Detectable Neovascularity in Patients with Cardiac Myxoma

Zhou

2021

CVIA

View full text Add to dashboard Cite

show abstract

Role of Selective Coronary Arteriography in Patients with Cardiac Myxoma

Cited by 1 publication

References 10 publications

Clinical Significance of Angiographically Detectable Neovascularity in Patients with Cardiac Myxoma

Clinical Significance of Angiographically Detectable Neovascularity in Patients with Cardiac Myxoma

Contact Info

Product

Resources

About